Hilario Yankey, MD, MBA

Hilario Yankey resized

Assistant Professor, Radiation Oncology

Specialties

  • Genitourinary Radiation Oncology
  • Gynecologic Radiation Oncology

Treatment Focus

  • Adaptive Radiotherapy 
  • Stereotactic Body Radiation Therapy (SBRT) 
  • Intensity Modulated Radiation Therapy (IMRT) 
  • Image-Guided Radiation Therapy (IGRT) 
  • Hypofractionated Radiation Therapy 
  • Ultra Hypofractionated Radiation Therapy 
  • Re-irradiation 
  • Brachytherapy 
  • Oligometastatic treatment

Treatment Philosophy

Growing up in an area with limited healthcare resources, I witnessed the profound impact of disease, fostering my deep respect for life and the power of effective treatment. As a radiation oncologist, I prioritize a patient-centered approach, working collaboratively to understand your unique needs and treatment goals. Building trust through clear and honest communication, I keep you informed and involved in every decision. Listening attentively to your concerns and utilizing the best technology, I aim to develop a personalized treatment plan that maximizes success while minimizing side effects. My commitment to excellence drives me to continually learn and integrate the latest research, ensuring you receive the most advanced care available.

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Educational Background

  • Temple University Hospital/Fox Chase Cancer Center (TUH/FCCC), Philadelphia, PA -  Radiation Oncology Residency, July 2020 – June 2024
  • Crozer Chester Medical Center, Upland (CCMC), PA Internal Medicine Transitional Year Residency, June 2019 – June 2020
  • Temple University [Lewis Katz] School of Medicine (TUSM), Philadelphia, PA Doctor of Medicine, August 2015 – May 2019 
  • Drexel University, Philadelphia, PA Bachelor of Science, Cellular and Molecular Biology, September 2011 – June 2015 
  • University of Ghana, School of Pharmacy, Accra, Ghana Bachelor of Pharmacy, September 2010 – June 2011

Honors & Awards

  • Dean’s List – Drexel University 2011 – 2015
  • Dean’s Merit Scholarship – Drexel University 2011 – 2015
  • Magna Cum Laude – Drexel University 2011 – 2015
  • TUSM Academic Achievement Award [Merit Full Scholarship] 2015 – 2019
  • CCMC Excellence in Research Award [First Place] 2020
  • Dean’s Merit Scholarship – Widener Business School 2022 – 2023
  • Outstanding Performance in MBA-HCM Program – Widener Business School 2024
  • Chief Resident – TUH/FCCC Radiation Oncology Program 2022 – 2023

Selected Publications

Yankey H, Ruth K, Dotan E, Reddy SS, and Meyer JE. Survival and Toxicity in Patients with Unresectable or Inoperable Biliary Tract Cancers with Ablative Radiotherapy versus Non-Ablative Chemoradiation. Advances in Radiation Oncology. 2023; 9(4): 101412

Shulman RM, Weinberg DS, Ross EA, Ruth K, Rall GF, Olszanski AJ, Helstrom J, Hall MJ, Judd J, Chen DYT, Uzzo RG, Dougherty TP, Williams R, Geynisman DM, Fang CY, Fisher RI, Strother M, Huelsmann E, Adige S, Whooley PD, Zarrabi K, Gupta B, Iyer P, McShane M, Yankey H, Lee CT, Burbure N, Laderman LE, Giurintano J, Reiss S, Horwitz EM. Adverse Events Reported by Patients with Cancer after Administration of a 2-Dose mRNA COVID-19 Vaccine. Journal of the National Comprehensive Cancer Network. 2022; 202: 160-166

Correa AF, Yankey H, Li T, Chen DY, Kutikov A, Uzzo RG, Geynisman DM, Joshi SS, Smaldone MC, Viterbo R. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2019; 123: 174180

Nausheen J, Harounian J, Yankey H. Dysphagia Evaluation and Management in Otolaryngology: Zenker’s Diverticulum, Department of Otolaryngology, Lewis Katz School of Medicine at Temple University Hospital. Elsevier. 2019. ISBN-13: 978-0323569309

Yankey H & Isaacson G. Efficacy of Topical 2% Mupirocin Ointment for Treatment of Tympanostomy Tube Otorrhea Caused by CA-MRSA. International Journal of Pediatric Otorhinolaryngology. 2018; 109: 36–39

Yankey H, Meyer JE, Anaokar J. Absence of fibrosis after Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) in a Multiple-transplant Patient. Applied Radiation Oncology. 2018; 4: 38- 42 Arosarena OA, Barr EW, Thorpe R, Yankey H, Tarr JT, Safadi FF. Osteoactivin Regulates Head and Neck Squamous Cell Carcinoma Invasion by Modulating Matrix Metalloproteases. Journal of Cellular Physiology. 2017; 233 (1): 409–421

 

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient comments

Loading ...